典型文献
Chemotherapy-Induced Myelosuppression in Esophageal Cancer Patients:Risks and Suggestions for Its Management
文献摘要：
[Summary]Objective:The influential factors of chemotherapy-induced myelosuppression in esophageal cancer in central China are unclear.This study aimed to investigate the effect of commonly used chemotherapy regimens on the incidence of myelosuppression in clinical treatment of esophageal cancer.Methods:In this retrospective study,624 patients with esophageal cancer who received six different chemotherapy regimens between 2013 and 2020 at our institute were included.Chemotherapy consisted of lobaplatin,5-fluorouracil(5-F),lobaplatin and 5-F,nedaplatin,nedaplatin and paclitaxel(PTX),cisplatin and PTX.Multivariable logistic regression analysis was used to explore the risk of myelosuppression among the six different chemotherapy regimens.Results:Compared with lobaplatin group,the incidence of myelosuppression in patients treated with chemotherapy regimens of lobaplatin and 5-F,nedaplatin,nedaplatin and PTX and cisplatin and PTX were significantly ameliorated.The dose of lobaplatin was significantly reduced(P=0.007)when lobaplatin was combined with 5-F,and the combination could significantly reduce the risk of myelosuppression(P=0.022).Furthermore,chemotherapeutic regimens,the dose of platinum,hemoglobin and uric acid levels,age,sex,total bilirubin and immune-enhancing drugs were found to be strong predictors of developing myelosuppression.Conclusion:Targeted preventive interventions that enhance immune function,reduce uric acid levels and choose combined medication during chemotherapy should be implemented for high-risk patients to reduce the occurrence of myelosuppression.In addition,the dose of lobaplatin should be adjusted when combined with other chemotherapy drugs to reduce the incidence of myelosuppression.
文献关键词：
中图分类号：
作者姓名：
Qi-lin ZHANG;Ting-ting WU;Yong HAN;Zi-ming ZHENG;Yu ZHANG
作者机构：
Department of Pharmacy,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Hubei Province Clinical Research Center for Precision Medicine for Critical Illness,Wuhan 430030,China
文献出处：
引用格式：
[1]Qi-lin ZHANG;Ting-ting WU;Yong HAN;Zi-ming ZHENG;Yu ZHANG-.Chemotherapy-Induced Myelosuppression in Esophageal Cancer Patients:Risks and Suggestions for Its Management)[J].当代医学科学(英文),2022(03):530-537
A类：
Myelosuppression,lobaplatin,nedaplatin
B类：
Chemotherapy,Induced,Esophageal,Cancer,Patients,Risks,Suggestions,Its,Management,Summary,Objective,influential,factors,chemotherapy,induced,myelosuppression,esophageal,cancer,central,China,unclear,This,study,aimed,investigate,effect,commonly,used,regimens,incidence,clinical,treatment,Methods,this,retrospective,patients,who,received,six,different,between,institute,were,included,consisted,fluorouracil,paclitaxel,PTX,cisplatin,Multivariable,logistic,regression,analysis,was,explore,risk,among,Results,Compared,group,treated,significantly,ameliorated,dose,reduced,when,combined,combination,could,Furthermore,chemotherapeutic,platinum,hemoglobin,uric,acid,levels,sex,total,bilirubin,immune,enhancing,drugs,found,strong,predictors,developing,Conclusion,Targeted,preventive,interventions,that,enhance,function,choose,medication,during,should,implemented,high,occurrence,addition,adjusted
AB值：
0.464491
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
